CRYOPORT, INC. Debt Securities, Available-for-sale, Realized Loss
CRYOPORT, INC. (CYRX) reported Debt Securities, Available-for-sale, Realized Loss of $851.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2025-05-08
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for the quarter ending 2025-03-31 was $851.00K.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for the quarter ending 2024-12-31 was $102.00K, a 1940.00% increase year-over-year.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for the quarter ending 2024-03-31 was -$2.42M.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for the quarter ending 2023-12-31 was $5.00K.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for fiscal 2024 was $4.09M, a 6005.97% increase from fiscal 2023.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for fiscal 2023 was $67.00K, a 34.31% decline from fiscal 2022.
- CRYOPORT, INC. debt securities, available-for-sale, realized loss for fiscal 2022 was $102.00K.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month | Debt Securities, Available-for-sale, Realized Loss 12 month |
|---|---|---|---|---|
| 2025-03-31 | $851.00K 10-Q · filed 2025-05-08 | $953.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2024-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $4.09M 10-K · filed 2025-03-07 | ||
| 2024-09-30 | $3.99M 10-Q · filed 2024-11-07 | |||
| 2024-03-31 | -$2.42M 10-Q · filed 2025-05-08 | -$2.41M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $67.00K 10-K · filed 2025-03-07 | ||
| 2023-09-30 | $62.00K 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $102.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |